BERNASCONI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 5.678
EU - Europa 4.190
AS - Asia 3.255
SA - Sud America 12
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 13.148
Nazione #
US - Stati Uniti d'America 5.639
CN - Cina 2.967
UA - Ucraina 1.003
IE - Irlanda 981
FI - Finlandia 569
DE - Germania 532
SE - Svezia 429
IT - Italia 373
SG - Singapore 245
GB - Regno Unito 163
FR - Francia 85
CA - Canada 38
JP - Giappone 17
NL - Olanda 16
BE - Belgio 14
RU - Federazione Russa 10
IN - India 8
BR - Brasile 7
IR - Iran 7
RO - Romania 7
EU - Europa 5
MU - Mauritius 4
AU - Australia 3
IL - Israele 3
CZ - Repubblica Ceca 2
GR - Grecia 2
MN - Mongolia 2
PY - Paraguay 2
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
IQ - Iraq 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MX - Messico 1
PT - Portogallo 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 13.148
Città #
Jacksonville 1.240
Chandler 1.073
Dublin 981
Nanjing 949
Boardman 436
Nanchang 413
Ashburn 386
Shenyang 270
Princeton 262
Lawrence 261
Hebei 254
Changsha 247
Wilmington 228
Jiaxing 206
Medford 179
Singapore 151
Tianjin 146
Hangzhou 137
New York 122
Beijing 112
Ann Arbor 109
Milan 81
Helsinki 76
Woodbridge 50
Norwalk 48
Shanghai 42
Verona 39
Toronto 34
Seattle 28
Jinan 26
Des Moines 24
Fairfield 23
Kunming 21
Los Angeles 21
Pavia 21
Zhengzhou 20
Ningbo 18
Tokyo 17
Brussels 14
Falls Church 12
Washington 12
Guangzhou 11
Houston 11
Lanzhou 10
Rome 10
Taizhou 10
Auburn Hills 9
Fuzhou 9
Novokuznetsk 7
Orange 7
Changchun 6
Meppel 6
Pune 6
Redwood City 6
Bergamo 5
Borås 5
Dallas 5
Palermo 5
Andover 4
Bologna 4
Monmouth Junction 4
Siena 4
Tappahannock 4
Taranto 4
Zanjan 4
Ardabil 3
Cologno Monzese 3
Cormano 3
Esslingen am Neckar 3
Florence 3
Leawood 3
Mozzecane 3
Pescara 3
Santa Clara 3
Turi 3
Aragona 2
Berlin 2
Bisacquino 2
Carini 2
Cava 2
Chicago 2
Dearborn 2
Fayetteville 2
Guanzate 2
Haikou 2
Lamporo 2
London 2
Melbourne 2
Pisa 2
Piscataway 2
Poggio Mirteto 2
Ponte San Pietro 2
Porto 2
Rescaldina 2
San Francisco 2
Tel Aviv 2
Torino 2
Trezzo sull'Adda 2
Triggiano 2
Turin 2
Totale 9.025
Nome #
FISH vantaggi e svantaggi 114
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 94
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. 88
Autologous stem cell transplantation following heart transplantation for AL amyloidosis 87
La citogenetica e la biologia molecolare nella valutazione del chimerismo e della malattia minima residua 85
Alcaloidi della vinca e dell'epipodofillotossina 82
Validation of the new comprehensive cytogenetic scoring system (NCCSS) on 630 consecutive de novo MDS patients from a single institution. 80
Impiego della citosina a basse dosi: risultati global 78
Citosina arabinoside a basse dosi con o senza 1,25diidrossi vitamina D3 nella terapia delle sindromi mielodisplastiche e nele leucemie acute dell’anziano 78
Anemia refrattaria con eccesso di blasti : caratteristiche clinico-ematologiche ed implicazioni terapeutiche 77
A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome. 75
Blast phase of essential thrombocythemia: A single center study. 74
Analisi in citometria a flusso dei pattern differenziativi della leucemia mieloide cronica in crisi blastica. Uno studio immunofenotipico di 26 casi consecutivi 74
Alterazioni dell’emostasi nelle leucemie e nei tumori solidi 73
Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? 72
Valutazione prognostica dele sindromi mielodisplastiche 72
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 72
[Multiple myeloma localized in the superior maxillary. Description of an uncommon case]. 71
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and nontoxic treatment for advanced follicular and mantle cell lymphoma 71
Analisi citogenetica e molecolare in onco-ematologia: rilevanza per diagnosi, prognosi e scelte terapeutiche 71
Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients 70
Chemioterapia della leucemia acuta linfoblastica dell’adulto: l’induzione della remissione e la profilassi meningea 70
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients 70
Central nervous system relapse in acute promyelocytic leucemia 69
Leucemia mielomonocitica cronica 69
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia 69
Outcome of four patients with chronic myeloid leucemia after imatinib mesylate discontinuation. 68
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma 68
Significance of MLC for BMT with serological HLA-identical related and unrelated donors 68
A complex chromosome 3 rearrangement not affecting RPN1, EVI1/MDS1 genes in a patient with an atypical refractory cytopenia with multilineage dysplasia. 67
Alterazioni del cariotipo nelle sindromi mielodisplastiche: significato patologico e clinico 67
Iperplasia gengivale da Ciclosporina-A nel paziente emopatico: considerazioni cliniche 67
Alterazioni Citogenetiche nelle sindromi mielodisplastiche 66
Acute nonlymphocytic leukemia : evidence of clonogenic cells in perypheral blood early in complete remission 66
Selezione delle cellule CD 34 positive. 66
Acute myeloid leukemia and diabetes insipidus: results in five patients 66
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis 65
ACUTE MYELOID LEUKEMIA (AML) HAVING EVOLVED FROM ESSENTIAL THROMBOCYTHEMIA (ET): DISTINCTIVE CHROMOSOME ABNORMALITIES IN PATIENTS TREATED WITH PIPOBROMAN OR HYDROXYUREA 65
A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma 65
Importanza clinica della malattia minima residua nel post-trapianto” Progetto “Progressi in Biologia e Medicina 65
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells 65
Autoimmunita’ nella malattia da trapianto contro l’ospite 64
Controllo delle infezioni nelle leucemie acute 64
Treatment of relapsed and refractory acute myloid leukemia in adults 64
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 64
Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci. 63
Rischio infettivologico in pazienti affetti da leucemia acuta e sottoposti a trapianto di midollo osseo autologo. Studio di 14 casi 63
Il controllo odontostomatologico nel paziente affetto da emopatia maligna: studio preliminare 63
Allogeneic versus autologous BMT versus intensive post-remission chemotherapy in acute leukemias 62
Exercise intolerance at high altitude (5050 m): critical power and W'. 62
Molecularly targeted therapy in acute myeloid leukemia. 61
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 61
Le sindromi mielodisplastiche : molteplicita’ degli aspetti ematologici e clinici 61
Interessamento del cromosoma 3 nelle mielodisplasie (MDS) 61
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 61
Impiego clinico di agenti antineoplastici ad alte dosi in oncoematologia: methotrexate e citosina arabinoside 60
Interferon alpha2b in the treatment of Ph1 negative myeloproliferative disoders with excessive thrombocytosis 60
Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma. 59
Treatment of Ph1 positive chronic myelogenous leukemia (CML) with recombinant interferon alpha 2b (Intron A) 59
Telomero e telomerasi:biologia e osservazioni preliminari nelle neoplasie ematologiche 58
INQUADRAMENTO PROGNOSTICO DELLE SMD 58
IL SISTEMA TELOMERO/TELOMERASI: UN NUOVO BERSAGLIO IN EMATOLOGIA/ONCOLOGIA 58
Growth factors in the therapy of myelodisplasia: biological aspects. 58
A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) 58
Role of the molecular staging and response in the management of follicular lymphoma patients 58
Significato clinico delle alterazioni citogenetiche nelle mielodisplasie studio di 60 pazienti 58
Evolving approaches with alpha interferon in chronic myelogenous leukemia 58
Etoposide : il citostatico della linea monocitica 58
Trapianto di midollo osseo nelle sindromi mielodisplastiche e nelle leucemie acute evolute da sindrome mielodisplastica 58
Alterazioni citogenetiche nelle leucemie acute 58
Alterazioni citogenetiche nelle leucemie linfatiche croniche 58
Ara-c ad alte dosi (HD-Ara-c) per il trattamento della malattia meningea nella leucemia acuta linfoblastica (LAL) e nei Linfomi non Hodgkin (LNH): studio di 25 casi 58
Incidenza della monosomia 7 in corso di crisi blastica della leucemia mieloide cronica (LMC) Ph1 positiva 58
Classificazione citogenetica delle LAM: impatto prognostico e terapeutico 57
Nephrotic sindrome after allogeneic hemopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease 57
Raccolta di cellule staminali emopoietiche da sangiue periferico dopo chemioterapia nella leucemia mieloide acuta 57
Burkitt’s lymphoma/leukemia : a clinico-pathologic study on 24 adult patients. 57
Fattori di crescita emopoietici (G-CSF e GM-CSF) nel trapianto di midollo osseo allogenico 57
ABL1 amplification in T-cell acute lymphoblastic leukemia. 57
Hematopoietic growth factors in bone marrow transplantation 56
Modalità di crescita delle CFU-GM in pazienti affetti da LMC in rapporto a differenti tipi di siero 56
Il contributo della citogenetica e della ibridazione in situ nella valutazione della MRD nelle emopatie 56
Mielodiplasia secondarie a prgressa terapia antineoplastica 56
Growth of human hemopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor 56
FuseFISH: Robust detection of transcribed gene fusions in single cells 56
Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation. 56
MECCANISMI MOLECOLARI E CELLULARI DELLA TRASFORMAZIONE LEUCEMICA NELLE SMD 56
Bone Marrow transplantation from unrelated donors in myelodysplastic syndromes 55
Crioglobulinemie: manifestazioni cliniche 55
Criopreservation of marrow cells for ABMT : is there any effect on the harvested leukemic cell? 55
Complicanze emorragiche e trombotiche nel paziente chirurgico 55
Storia naturale e trasformazione istologico/clinica dei linfomi a bassa malignita’. 55
Strategie per la mobilizzazione di progenitori emopoietici nel sangue periferico 55
Targeting Ubiquitin in cancers 54
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making 54
Porpora trombocitopenica immunologica cronica in gravidanza 54
Pathogenetic significance of “pure” monosomy 7 in myeloproliferative disorders. Analyses of 14 cases 54
Mitoxantrone: clinical safety and tolerance in hematologic malignancies 54
Alternative Splicing of hTERT: a further Mechanism for the Control of Active hTERT in Acute Myeloid Leukaemia 54
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy? 53
Totale 6.420
Categoria #
all - tutte 51.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020785 0 0 0 0 6 208 34 211 5 279 40 2
2020/20211.825 222 178 58 193 7 243 6 264 63 270 265 56
2021/20221.016 14 7 37 15 26 64 19 82 61 23 156 512
2022/20233.163 363 203 7 259 394 367 0 219 1.191 25 83 52
2023/20241.132 102 213 30 109 112 401 8 65 11 33 13 35
2024/2025596 47 323 76 98 52 0 0 0 0 0 0 0
Totale 13.268